Skip to main content

Flow Cytometric Immunophenotyping as Diagnostic Tool of Hematopoietic Malignancies

  • Chapter
  • First Online:
Molecular Aspects of Hematologic Malignancies

Abstract

Flow cytometry is a diagnostic technique capable of distinguishing cells by their size, internal complexity, and antigen repertoire (phenotype) with the use of monoclonal antibodies conjugated with fluorescent dyes. Nowadays, flow cytometry has become a highly specific and fully reproducible method for the diagnosis of hematological malignancies. Flow cytometry allows for the analysis of any type of sample prepared as a single cell suspension, e.g., blood, bone marrow, cerebrospinal fluid, as well as homogenized solid tissues like lymph nodes. The detailed phenotypic features of the analyzed cells depend on the number of simultaneously used monoclonal antibodies, which is in turn dependent on the flow cytometer specification. Flow cytometric assays, particularly immunophenotyping, have broad clinical applications, especially in the diagnostics of hematological malignancies (e.g., acute lymphoblastic leukemia—ALL, acute myeloid leukemia—AML and chronic lymphoproliferative disorders—CLPD), based on precise determination of the lineage, maturation stage and phenotypic aberrancies of tumor versus normal/reactive cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutour P, Estienne MH, Davi F, Landman-Parker J, Quartier P, Buzyn A, Delabesse E, Valensi F, Macintyre E (2003) Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 101:2693–2703

    Article  PubMed  CAS  Google Scholar 

  • Barrena S, Almeida J, Del Carmen Garcia-Macias M, Lopez A, Rasillo A, Sayagues JM, Rivas RA, Gutierrez ML, Ciudad J, Flores T, Balanzategui A, Caballero MD, Orfao A (2011) Flow cytometry immunophenotyping of fine-needle aspiration specimens: utility in the diagnosis and classification of non-Hodgkin lymphomas. Histopathology 58:906–918. doi:10.1111/j.1365-2559.2011.03804.x

    Google Scholar 

  • Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van’t Veer MB (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9:1783–1786

    PubMed  CAS  Google Scholar 

  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103:620–625

    PubMed  CAS  Google Scholar 

  • Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K (2011) Peripheral T-cell lymphoma. Blood 117:6756–6767

    Article  PubMed  CAS  Google Scholar 

  • Givan AL (2004) Flow cytometry: an introduction. Methods Mol Biol 263:1–32

    PubMed  Google Scholar 

  • Gorczyca W, Weisberger J, Liu Z, Tsang P, Hossein M, Wu CD, Dong H, Wong JY, Tugulea S, Dee S, Melamed MR, Darzynkiewicz Z (2002) An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. Cytometry 50:177–190

    Article  PubMed  Google Scholar 

  • Greaves MF, Janossy G, Peto J, Kay H (1981) Immunologically defined subclasses of acute lymphoblastic leukemia in children: their relationship to presentation features and prognosis. Br J Hematol 48:179–197

    CAS  Google Scholar 

  • Herzenberg LA, Parks D, Sahaf B, Perez O, Roederer M, Herzenberg LA (2002) The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. Clin Chem 48:1819–1827

    PubMed  CAS  Google Scholar 

  • Jaffe ES (2009) The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematol Am Soc Hematol Educ Program 113:523–531

    Google Scholar 

  • Karube K, Aoki R, Nomura Y, Yamamoto K, Shimizu K, Yoshida S, Komatani H, Sugita Y, Ohshima K (2008) Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases. Pathol Int 58:89–97

    Article  PubMed  Google Scholar 

  • Maecker HT, Trotter J (2006) Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69:1037–1042

    PubMed  Google Scholar 

  • Mahnke YD, Roederer M (2007) Optimizing a multicolor immunophenotyping assay. Clin Lab Med 27:469–485

    Article  PubMed  Google Scholar 

  • Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 363:105–111

    Article  PubMed  CAS  Google Scholar 

  • Orfao A, Ortuño F, de Santiago M, Lopez A, San Miguel J (2004) Immunophenotyping of acute leukemias and myelodysplastic syndromes. Cytometry A 58:62–71

    Article  PubMed  Google Scholar 

  • Orfao A, Lopez A, Flores J, Almeida J, Vidriales BM, Perez J, Kneba M, Macintyre E, Parreira A, Richards S, Szczepański T, Trka J, van der Velden VHJ, van Dongen JJM (2006) Diagnosis of haematological malignancies: new applications for flow cytometry. Hematology 5:6–13 (Education Program of the 11th Congress of the European Hematology Association, Amsterdam, The Netherlands June 15–18, 2006)

    Google Scholar 

  • Palumbo GA, Parrinello N, Fargione G, Cardillo K, Chiarenza A, Berretta S, Conticello C, Villari L, Di Raimondo F (2009) CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Leuk Res 33:1212–1216

    Article  PubMed  CAS  Google Scholar 

  • Porwit-MacDonald A, Björklund E, Lucio P, van Lochem EG, Mazur J, Parreira A, van den Beemd MW, van Wering ER, Baars E, Gaipa G, Biondi A, Ciudad J, van Dongen JJ, San Miguel JF, Orfao A (2000) BIOMED-1 concerted action report: flow cytometric characterization of CD7 + cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL). Leukemia 14:816–825

    Article  PubMed  CAS  Google Scholar 

  • Radcliff G, Jaroszeski MJ (1998) Basics of flow cytometry. Methods Mol Biol 91:1–24

    PubMed  CAS  Google Scholar 

  • Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues (4th ed). IARC, Lyon, France

    Google Scholar 

  • Szczepański T, Orfao A, van der Velden VHJ, San Miguel JF, van Dongen JJ (2001) Minimal residual disease in leukaemia patients. Lancet Oncol 2:409–417

    Article  PubMed  Google Scholar 

  • Szczepański T, van der Velden VHJ, van Dongen JJM (2003) Classification systems for acute and chronic leukaemias. Best Pract Res Clin Haematol 16:561–582

    Article  PubMed  Google Scholar 

  • Szczepański T, van der Velden VHJ, van Dongen JJM (2006) Flow-cytometric immunophenotyping of normal and malignant lymphocytes. Clin Chem Lab Med 44:775–796

    PubMed  Google Scholar 

  • Van Wering ER, van Lochem EG, Leenders M, van der Sluijs-Gelling AJ, Wind H, Gratama JW, Kraan J, Preijers FW (2004) Three-color flowcytometric analysis of mature and immature hematological malignancies. A guideline of the Dutch Foundation for Immunophenotyping of Hematological Malignancies (SIHON). J Biol Regul Homeost Agents 18:313–326

    PubMed  Google Scholar 

  • Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951

    Article  PubMed  CAS  Google Scholar 

  • Wood B (2007) Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia. Clin Lab Med 27:551–575

    Article  PubMed  Google Scholar 

  • Zola H, Swart B, Banham A, Barry S, Beare A, Bensussan A, Boumsell L, Buckley CD, Bühring HJ, Clark G, Engel P, Fox D, Jin BQ, Macardle PJ, Malavasi F, Mason D, Stockinger H, Yang X, Stockinger H, Yang X (2007) CD molecules 2006—human cell differentiation molecules. J Immunol Methods 319:1–5

    Google Scholar 

  • Zucchetto A, Bomben R, Dal Bo M, Bulian P, Benedetti D, Nanni P, Del Poeta G, Degan M, Gattei V (2006) CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance. Leukemia 20:523–525

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Łukasz Sędek .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sędek, Ł. et al. (2012). Flow Cytometric Immunophenotyping as Diagnostic Tool of Hematopoietic Malignancies. In: Witt, M., Dawidowska, M., Szczepanski, T. (eds) Molecular Aspects of Hematologic Malignancies. Principles and Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29467-9_9

Download citation

Publish with us

Policies and ethics